CABALETTA BIO INC. - COMMON STOCK
2,6500
07-февраля-25 15:45:00
15 мин. задержка
Акции
+0,0500
+1,92%
Сегодняшний диапазон
2,5400 - 2,7600
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference
29 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025
13 янв 2025 07:00:01 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in December
26 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
18 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
14 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
06 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
25 сен 2024 15:30:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
28 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
08 авг 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum
02 июл 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
14 июн 2024 01:00:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
29 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
15 май 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
13 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
21 мар 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
20 мар 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in March
27 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis
01 фев 2024 15:30:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
31 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
08 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >